Literature DB >> 16100781

The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future.

P M Poortmans1, J B Davis, F Ataman, J Bernier, J-C Horiot.   

Abstract

As early as in 1982, the European Organisation for Research and Treatment of Cancer Radiotherapy Group established a quality assurance programme. In the course of 20 years, quality assurance procedures have become a vast and important part of the activities of the group. Today, the membership committee uses standard procedures based on minimal requirements to evaluate current members and new membership applications. Moreover, for every new trial, specific quality assurance procedures are an integral part of the preparation of the protocol and executed under the responsibility of the study coordinator. With the growing complexity of the radiotherapy techniques used in the framework of the more recent trials, quality assurance procedures have also become more complex including trial specific phantom based measurements. Future ways to evaluate all steps of the radiotherapy process using a common platform connecting all users with the internet are currently under development.

Entities:  

Mesh:

Year:  2005        PMID: 16100781     DOI: 10.1016/j.ejso.2005.02.014

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  4 in total

1.  Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303.

Authors:  Naoko Sanuki; Satoshi Ishikura; Masayuki Shinoda; Yoshinori Ito; Kazushige Hayakawa; Nobutoshi Ando
Journal:  Int J Clin Oncol       Date:  2011-06-14       Impact factor: 3.402

2.  Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.

Authors:  Agata I Rembielak; Pooja Jain; Andrew S Jackson; Melanie M Green; Gillian R Santorelli; Gillian A Whitfield; Adrian Crellin; Angel Garcia-Alonso; Ganesh Radhakrishna; James Cullen; M Ben Taylor; Ric Swindell; Catharine M West; Juan Valle; Azeem Saleem; Patricia M Price
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

Review 3.  [Quality criteria for treatment of colorectal cancer. From a surgeon's viewpoint].

Authors:  K H Link; M Kornmann; R Bittner; F Köckerling; R Arbogast; I Gastinger; W Heitland; D Henne-Bruns; H Lang; H Lippert; M Mann; H J Meyer; M-J Polonius; S Post; R Raab; T Schiedeck; V Schumpelick
Journal:  Chirurg       Date:  2010-03       Impact factor: 0.955

4.  Beam Output Audit results within the EORTC Radiation Oncology Group network.

Authors:  Coen W Hurkmans; Melissa Christiaens; Sandra Collette; Damien Charles Weber
Journal:  Radiat Oncol       Date:  2016-12-15       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.